Related by context. All words. (Click for frequent words.) 71 mertansine 71 SIX RO ROG 70 anti gastrin monoclonal 70 Kosan dependence 70 PORxin TM platforms 70 oncolytic virus therapies 69 pipeline ImmunoGen collaborators 69 kidney urologic 69 commercialize SGN 69 ImmunoGen maytansinoid TAP 69 Selective Electrochemical Tumor Ablation 69 Nanobody R 68 gastro intestinal inflammation 68 Potelligent 68 GVAX ® 68 Septin9 biomarker 68 LungAlert TM 68 TLR9 agonists 68 HuMax TAC 68 small molecule glucokinase 68 POTELLIGENT R 68 proprietary MSCRAMM ® 68 MSCRAMM ® 68 include ColorectAlert TM 68 commercialize deforolimus 67 deCODE ProstateCancer TM 67 CYT# potent vascular disrupting 67 humanised antibody 67 compound KOS 67 OncoVex 67 Roche SWX ROG 67 INxin TM 67 telomerase therapeutic 67 targeting miR 67 Prodarsan R 67 DEB# 67 progressive metastatic prostate 67 POTELLIGENT ® Technology 67 LymphoStat B belimumab 67 cathepsin K inhibitor 67 POTELLIGENT ® 67 Kosan epothilone program 67 staphylococcal vaccine 67 targeted anticancer therapies 67 MCSP respectively 67 novel therapeutic antibodies 67 LentiVector technology 67 EHT AGN 66 Albuferon albinterferon alfa 2b 66 immunotherapeutic approaches 66 Modrenal R 66 GlaxoSmithKline MedImmune 66 PDE4 inhibitor 66 MAGE A3 ASCI 66 PF # [002] 66 attach auristatin 66 Provectus Pharmaceuticals specializes 66 PEGylated interferon 66 Cerashield ™ 66 TRIOLEX HE# APOPTONE HE# 66 acyclovir Lauriad R 66 Crucell PER.C6 66 EC Cysteamine 66 Scancell 66 candidate custirsen 66 cosmetic cosmeceutical products 66 Crofelemer budesonide foam 66 Taisho Pharmaceuticals 66 PrevOnco ™ 66 R sorafenib tablets 66 therapeutic monoclonal antibody 66 Quark Biotech 66 XL# anticancer compounds 66 XL# XL# XL# XL# 66 Tykerb lapatinib 66 proprietary PEGylation 66 ADCC enhanced 66 DNA methylation biomarkers 66 Exelixis compounds 66 candidates Azedra TM 66 HCV NS5B polymerase 66 HuMax 66 Albugon 66 Argatroban 66 recurrent metastatic ovarian cancer 66 deCODE AF TM 66 including eniluracil ADH 66 Dyax phage display 66 P#X# antagonist 66 Vaxfectin 66 CD# CEA 65 Olaparib 65 ChromoCure develops 65 trastuzumab DM1 T DM1 65 MERREM 65 IMiDs ® 65 POTELLIGENT R Technology 65 monoclonal antibody MAb 65 Locked Nucleic Acid 65 Merck Serono Nycomed 65 enhanced skin permeation 65 introduced NEUGENE 65 hypoxia selective 65 Syncria 65 targeted anticancer biopharmaceuticals 65 GW# [003] 65 optical biosensors 65 thalidomide Thalomid 65 staphylococcal vaccines 65 reverse vaccinology 65 Potelligent TM Technology 65 Rigel R# 65 Veronate R 65 humanized monoclonal antibodies 65 Ceragenin ™ 65 anti CD3 monoclonal 65 Nexavar sorafenib tablets 65 mSEPT9 biomarker 65 therapeutic peptide 65 Potelligent Technology 65 Pertuzumab 65 SPL# Gel vaginal microbicide 65 5 lipoxygenase activating 65 proprietary albumin fusion 65 Piperacillin 65 virosome 65 metaglidasen 65 GlycArt 65 rxRNA 65 chimeric monoclonal antibody 65 Archexin 65 regorafenib 65 ChronVac C R 65 LymphoStat B TM 65 sulfonylhydrazine class 65 Initiates Enrollment 65 anticancer therapeutics 65 NuMimetic TM 65 Nanobody 65 HepaMate 65 SCIB1 65 proprietary BiTE ® 65 Trastuzumab DM1 65 IG HCR ;) CO 65 RNA antagonists 65 THR beta agonist 65 novel antibody therapeutics 65 radiation chemoradiation 65 include Altastaph TM 64 pharmacogenomic translational research 64 AQUA ® 64 superparamagnetic iron oxide nanoparticles 64 Temsirolimus 64 Pruvel TM 64 visit www.genenews.com 64 romazarit 64 HYVISC ® treatment 64 HGS ETR1 mapatumumab 64 HuCAL PLATINUM ® CysDisplay 64 Campto 64 ZFP Therapeutics 64 TRAIL receptor antibodies 64 purinergic receptors P#X# 64 therapeutic monoclonal antibodies 64 Payload TAP technology 64 KuDOS 64 Empatic ™ 64 NovaBay Aganocide compounds 64 GRNOPC1 contains 64 HIV integrase inhibitor 64 Immunotherapeutic 64 Dynepo TM 64 Bayer HealthCare Onyx Pharmaceuticals 64 accumulate preferentially 64 UltiMAb TM 64 Liprotamase 64 small molecule thrombopoietin 64 molecular chaperone regulation 64 Boehringer Ingelheim MedImmune 64 developing Bicifadine serotonin 64 Nutra Pharma wholly owned 64 evaluating T DM1 64 product platforms AZX# 64 Locked Nucleic Acid LNA 64 Pancreate 64 Submits Biologics License Application 64 commercialize OncoGenex lead 64 mitiglinide 64 NS5b 64 Monoclonal antibody 64 recombinant PSMA vaccine 64 SAR# [002] 64 ACTCellerate 64 PSMA ADC 64 selective orally bioavailable 64 ribonucleotide reductase clinically validated 64 sorafenib tablets 64 antisense inhibitors 64 Viprovex R 64 ddRNAi 64 UltiMAb 64 Allovectin 7 64 Innovive Pharmaceuticals 64 Volumex Daxor single 64 patented BEMA 64 drug conjugate 64 Initiates Phase II 64 drug conjugate ADC 64 Initiates Clinical Trial 64 Gemzar gemcitabine 64 recombinant adeno associated 64 DPX Survivac 64 ViroChem 64 Smac mimetics 64 adrenergic regulation 64 BCR ABL inhibitors 64 proprietary BiTE R 64 Antibody Drug Conjugate 64 ZFP Therapeutic ® 64 Naglazyme R 64 Canvaxin TM 64 immatics 64 Copegus R 64 Genentech sanofi aventis 64 AERx ® 64 Aganocide ® 64 commercial bioproduction 64 R MSCRAMM 64 volociximab 64 RAS MAPK pathway 64 generation NEUGENE antisense 64 NanoStat 64 Fludara ® 64 anastrozole Arimidex 64 investigational integrase inhibitor 64 novel immunotherapies 64 TRANSDUR ™ 64 YONDELIS 64 psoriasis inflammatory bowel 64 PI3K/Akt pathway inhibitor 64 label Lipofen R 64 mGluR4 PAM 64 Elotuzumab 64 Onalta TM 64 AAG geldanamycin analog 64 Virulizin ® 64 Crucell PER.C6 ® 64 nasal calcitonin product 64 targeted radiotherapeutic 64 taxane derivative 64 proprietary capillary aerosolization 63 NPC 1C 63 Budesonide foam crofelemer 63 intravesical infusion therapy 63 HepDirect prodrug 63 Tofacitinib 63 TLR9 agonist 63 DXL TM antibodies 63 IMA# 63 myelofibrosis polycythemia vera 63 BioMAP ® Systems 63 CCR9 antagonist 63 delipidation 63 RELOVAIR ™ 63 demonstrated anti amnesic 63 humanized therapeutic 63 antiangiogenesis therapies 63 HER2 ErbB2 63 fluorinated carbohydrate mimics 63 Cobalamin TM mediated 63 Cobalamin TM 63 Dapagliflozin 63 Reports Preclinical Data 63 imaging radiopharmaceuticals 63 Nycomed GmbH 63 platforms GVAX 63 Survivin antagonist 63 NICE Recommends 63 TRACON Pharmaceuticals 63 Genasense evaluating 63 IMPACS R 63 Zolpimist ™ 63 rHuPH# recombinant human 63 Kuvan sapropterin dihydrochloride 63 Horizant ™ 63 nucleotide analogue 63 Mg Usa 63 vinorelbine tartrate 63 Tesmilifene 63 Endotis 63 vaccines oncolytic virus 63 Panzem R NCD 63 LEVADEX ™ 63 Captisol ® 63 novel VDA molecule 63 Daclizumab 63 sapacitabine CYC# 63 Cx# [002] 63 recombinant subunit vaccine 63 Mammostrat 63 erlotinib Tarceva ® 63 DGAT 63 immunotherapeutic agent 63 HuCAL antibody 63 aerosolized AAT 63 cleavable linker 63 GRNVAC1 63 Vitamin D analogue 63 personalized cellular immunotherapy 63 acadesine 63 ENMD # 63 infectious diseases autoimmune diseases 63 Completes Patient Enrollment 63 BRAF kinase 63 Aflibercept 63 BioSante 2A/Furin technology 63 recombinant biopharmaceutical 63 evaluating satraplatin 63 BIIB# 63 Oncotype DX colon cancer 63 CD4 monoclonal antibody 63 BiTE R 63 AEG# 63 Crucell genetically engineered 63 HIV protease inhibitor Lexiva 63 TLR7 agonist 63 oral dihydropyrimidine dehydrogenase DPD 63 M2 subunit 63 delta opioid receptor 63 apricitabine ATC 63 Eraxis 63 MVA BN R 63 IV meropenem 63 using Crucell PER.C6 63 Tibotec Therapeutics division 63 Vaccinex 63 oral prodrug 63 DNA methylation biomarker 63 OncoVEX 63 Alnylam RNAi 63 XL# XL# 63 Panzem NCD 63 IgG1 monoclonal antibody 63 hepatitis C lupus 63 immunotherapeutics 63 JAK inhibitor 63 Shark cartilage 63 RhuDex R 63 ADP receptor antagonist 63 tiapamil 63 Nasdaq MITI biopharmaceutical 63 rotavirus shingles 63 antibody MAb 63 Oral NKTR 63 anionic backbone 63 Nanobody ® 63 TOCOSOL Camptothecin 63 adenosine A2A 63 agonistic human 63 candidate deforolimus 63 oral proteasome inhibitor 63 MEK Inhibitor 63 next generation URAT1 63 LHRH antagonists 63 highly selective inhibitor 63 HuCAL antibodies 63 anti CD3 antibody 63 TLR agonists 63 Pfizer Selzentry 63 LEAPS TM 63 successfully commercialize Iluvien 63 produces potent VLP 63 Peyronie disease Frozen Shoulder 63 Chipscreen 63 exemestane Aromasin 63 CCX# 63 selective androgen receptor modulators 63 Epigenomics proprietary 63 Cerashield 63 LAS# [002] 63 proven proprietary AcuForm 62 GPR# agonist 62 AVAX AC Vaccine 62 Mg Uk 62 HepDirect R 62 metastatic colorectal 62 trastuzumab Herceptin R 62 fusion enhancers 62 PORxin TM 62 Pierre Fabre SA 62 signal averaging electrocardiography 62 targeted antifolate 62 Resurgex Plus R 62 oral ghrelin agonist 62 novel emulsion formulation 62 Xeloda ® 62 Staphylococcus aureus Immune Globulin 62 BRAF inhibitor 62 selective estrogen receptor modulator 62 Aurora kinase inhibitor 62 JAK2 inhibitor 62 siRNA compounds 62 Company TAIFUN R 62 Telatinib 62 Pharma Merck Serono 62 ELADUR ™ 62 Adnectin 62 delay bone metastases 62 anticancer compounds 62 platinum chemotherapeutic 62 oral PTH 62 Dacetuzumab 62 OncoGel 62 TRANSDUR ® 62 refractory metastatic 62 oral Janus kinase 62 psoriasis Crohn disease 62 specific CCR9 antagonist 62 Imatinib mesylate 62 liposome encapsulated 62 MSCRAMM R 62 Xcellerex FlexFactory 62 non nucleoside inhibitor 62 Xelox 62 HyACT 62 NEBIDO VANTAS SUPPRELIN LA 62 Proellex TM 62 Synerx 62 5 fluorouracil leucovorin 62 biochemical profiling 62 Avian Transgenic Technology 62 Litx 62 recombinant vaccines 62 Vidaza azacitidine 62 AdVac ® 62 Anticalins R 62 Tibotec BVBA 62 histone deacetylase HDAC 62 peptibody 62 HuCAL GOLD R 62 MEK inhibitors 62 Sustiva efavirenz 62 SEQureDx ™ 62 muco adhesive technology 62 targeted immunotherapies 62 Oragens TM 62 ovarian endometrial 62 SMaRT ™ 62 lintuzumab SGN 62 refractory chronic lymphocytic 62 chemistry microbiology immunology 62 mda 7 62 HepeX B TM 62 tubulin inhibitor 62 Nexavar sorafenib 62 SGLT Inhibitors 62 MKC# MKC# PP 62 alpha folate receptor 62 radiolabeled TM# 62 Merck OSI Pharmaceuticals 62 Inc. AMEX YMI 62 PLX MS 62 Ixempra 62 non nucleoside HCV 62 Davanat 62 OMP #M# 62 ospemifene 62 oral immunomodulatory 62 investigational immunotherapy 62 CDK cyclin dependent 62 IV Busulfex 62 eligen R technology 62 SynCon 62 Vytorin combines 62 irinotecan hydrochloride 62 CEL SCI Phase III 62 transcutaneous immunization TCI 62 Syncria albiglutide 62 Intravenous Human 62 Files IND 62 Prodarsan ® 62 diagnostic molecular imaging 62 EDEMA3 62 ocular formulation 62 recombinant antibodies 62 pralatrexate injection folate analogue 62 evaluating tivozanib 62 Currently RegeneRx 62 hereditary emphysema 62 protein receptors lectins 62 PrevOnco 62 systemic RNAi therapeutic 62 AstraZeneca AZN.L 行情 62 TFChem licenses 62 targeted alpha folate 62 Taxotere docetaxel 62 Umbilical cord stem cells 62 platform HDL Mimetic 62 HTS assay 62 oral antiviral 62 Vitrasert R 62 Spiegelmer 62 Epidermal Growth Factor Receptor 62 plus dacarbazine 62 lung pancreatic 62 Micromet BiTE 62 Darapladib 62 HuCNS SC ® 62 IMiDs R 62 ZACTIMA 62 TRIST study 62 epoetin zeta 62 proprietary attenuated Listeria 62 entinostat 62 Potelligent TM 62 About Allscripts Allscripts 62 Gammagard Liquid 62 commercialize becocalcidiol patented 62 liposomal formulation 62 ThermoDox R 62 inactivated strain 62 neratinib 62 FOLFOX6 chemotherapy regimen 62 Fleximer R 62 Endotoxin Activity Assay 62 Angiocept 62 InterfeRx 62 approved incretin mimetic 62 oral talactoferrin 62 Copegus ® 62 Naive Patients 62 Hepatocellular Carcinoma HCC 62 cMET 62 ALN PCS 62 mTOR kinase 62 HCV Hepatitis C 62 nilotinib Tasigna 62 tamoxifen Nolvadex ® 62 selective kinase inhibitor 62 developing Zerenex TM 62 carbohydrate polymers 62 Alfacell proprietary ribonuclease 62 DepoVax TM 62 basal cell carcinoma squamous 62 Pandel R 62 Cephalon GlaxoSmithKline 62 IMiDs 62 Isis antisense 62 Insegia 62 Gamunex C 62 GRN# 62 ALN TTR 62 adecatumumab MT# 62 MEDAREX 62 HCV polymerase 62 GeneICE 62 modified nucleoside 62 Genotyping Test 62 methylnaltrexone bromide 62 endothelin antagonist 62 EOquin TM phase 62 AFREZZA TM 62 Zolinza 62 Genentech Rituxan 62 A/Brisbane/#/# H#N# 62 Myocet 62 dasatinib Sprycel 62 Multi Lineage Progenitor 62 gastrin analogue TT 62 telomerase inhibitor 62 pentadentate logo R 62 Initiates Phase III 62 immuno therapeutic 62 Oragens R 62 PharmFilm ® 62 treat chronic sinusitis 62 candidate CRLX# 62 Campath alemtuzumab 62 PRN FDA Approves 62 rxRNA TM compounds 62 auristatin E MMAE 62 Provecta TM 62 telomerase inhibitor drug 62 Awarded Qualifying Therapeutic 62 LentiVector 62 cyclophilin inhibitors 62 Elvitegravir 62 multi kinase inhibitor 62 4SC AG ISIN DE# 62 Silodosin 62 oral nucleoside analogue 62 eligen 62 Triapine 62 BioFocus DPI Galapagos 62 letrozole Femara 62 dSLIM 62 Serostim ® 62 cellular immunotherapy 62 proprietary Customized Linker 62 novel nucleoside analog 62 VaxImmune 62 ® bortezomib 62 MKC# MT 62 commercialize Dimebon 62 vaccine GMK 62 deforolimus 62 docetaxel Taxotere R 62 Diamyd ® 62 MAbs targeting 62 ChemoFx 62 Combivir Kivexa 62 DG# compounds targeting 62 Ophthotech 62 Cellzome 62 ZapMedia applied 62 hyaluronidase enzyme 62 delta gamma agonist 62 ImmunoGen Tumor Activated Prodrug 62 Atripla combines 62 skeletal sarcomere activators 62 peptidic compound 62 Corus CAD 62 barrier gauze dressings 62 proteasome inhibitor 61 Chemetics R 61 include Healive TM 61 vapreotide acetate 61 therapeutic radiopharmaceuticals 61 paclitaxel Taxol ® 61 fight PI3K activation 61 SAR# [004] 61 Canvaxin 61 AcryMed technologies 61 antisense drug 61 StromaCel Inc. 61 Indibulin ZIO 61 conserved antigens NP 61 Etravirine 61 Health RxList theHeart.org 61 Azacitidine 61 commercialize apixaban 61 MVA BN ® 61 TELINTRA R 61 Virosome Biologicals 61 Epiphany Biosciences 61 docetaxel Taxotere ® 61 OGeS 61 antibiotic Tygacil 61 Pfenex Expression Technology 61 Syntonix Pharmaceuticals 61 Vidaza ® 61 HCD# [002] 61 Retisert ® 61 Loramyc ™ 61 JOULFERON 61 ONCONASE R 61 Talabostat 61 delivers fluocinolone acetonide FA 61 Nexavar tablets 61 Amgen discovers develops 61 Epothilones 61 protein tyrosine phosphatase 1B 61 developing TB4 61 Temodar ® 61 personalized dendritic 61 cilengitide 61 aurora kinase 61 Perforomist TM formoterol fumarate 61 pertuzumab 61 LHRH receptor positive 61 Transdel TM 61 Xanafide 61 MEK inhibitor 61 Vicinium TM 61 androgen receptor antagonist 61 TNF Tumor Necrosis Factor 61 Launches Generic Version 61 R Saizen R 61 lipid nanoparticle 61 equine osteoarthritis marketed 61 Euroscreen 61 product Fentanyl TAIFUN 61 Affibody ® molecules 61 Aloprim TM allopurinol sodium 61 Fovea Pharmaceuticals 61 Nanobodies 61 commercialize Aganocides 61 Namenda Memantine HCl 61 Piramed 61 ALN VSP 61 Aradigm Logo 61 proven DuraSite ® 61 evaluating picoplatin 61 novel immunomodulatory 61 RELOVAIR 61 product platforms GVAX 61 drug conjugates ADCs 61 Alkeran 61 trastuzumab Herceptin 61 VitiGam 61 IAP inhibitor 61 VersaFilm 61 5 HT3 antagonist 61 Lenocta TM sodium stibogluconate 61 Dealmaking Profile 61 aminocandin 61 Muraglitazar 61 USHE groundbreaking pocket BLU 61 bevacizumab Avastin ® 61 FUSILEV ® 61 histone deacetylase HDAC inhibitors 61 eTag assays 61 GI motility disorders 61 Inotek Pharmaceuticals Corporation 61 Alferon LDO 61 galiximab 61 Altera Nebulizer System 61 Euronext SAN 61 proprietary synthetic peptides 61 oral PTH technology 61 AlloMap molecular expression 61 gets USFDA nod 61 forodesine 61 selectively inhibit replication 61 OGAP R 61 receptor tyrosine kinase inhibitor 61 VitiGam TM 61 Zalypsis 61 KellBenx 61 CCR5 inhibitor 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 Boniva ibandronate 61 recombinant hepatitis B 61 plasmid DNA pDNA 61 CCR5 receptor antagonist 61 Thiovir 61 bendamustine HCl 61 VentiRx Pharmaceuticals 61 LNP formulations 61 Solaraze 61 infectious diseases autoimmune 61 Personalized Immunotherapy 61 AKT inhibitor 61 Janus Kinase 61 Aeolus Pharmaceuticals Announces 61 Tarceva TM 61 Pfizer Camptosar 61 antisense drugs 61 VEGFR2 inhibitor 61 DENVax 61 immunotherapeutic vaccine 61 HCV RNA polymerase 61 class mGluR5 inhibitor 61 Belimumab 61 etanercept Enbrel 61 Combunox 61 Alligator Bioscience AB 61 microtubule inhibitor 61 adult multipotent stem 61 AstraZeneca MedImmune 61 Annamycin 61 panitumumab Vectibix 61 eflornithine 61 FOLOTYN ® 61 delivery polymer matrix 61 SuperAntibody 61 RhuDex ® 61 Astex Therapeutics Limited 61 Cotara ® 61 OXIGON TM 61 Medarex UltiMAb R 61 topically applied SEPA 61 beta islets 61 Anidulafungin 61 lapatinib Tykerb 61 Levoleucovorin 61 selective immunoproteasome inhibitor 61 vinca alkaloid 61 CLIA certified laboratories 61 Initiate Clinical Trial 61 cardio metabolic diseases 61 Xeloda capecitabine 61 Receives Approvable Letter 61 FoldRx Pharmaceuticals Inc. 61 CORT # 61 reslizumab 61 PDE# inhibitors 61 metastatic pancreatic 61 IMiDs ® compound 61 MabThera rituximab 61 Xcellerated T Cells 61 noninvasive prenatal genetic 61 recombinant spider silk 61 Alseres Cethrin 61 Micromet proprietary BiTE 61 lead Aganocide compound 61 Kosan motilin agonist 61 PHX# 61 psoriasis rheumatoid arthritis 61 anti CD3 61 midstage clinical 61 gastrointestinal stromal 61 Telik logo TELINTRA 61 DP VPA 61 Factor Receptor 61 Crossflo DataExchange 61 HuLuc# 61 Maribavir 61 biologic therapeutics 61 developing Surfactant Replacement 61 potently inhibit 61 oral dual endothelin 61 subsidiaries visit http:/www.apricusbio.com 61 nucleoside analog 61 tumor suppressors cytokines 61 Biomerix Corporation 61 hormone LHRH antagonist 61 IMPDH inhibitor 61 BrachySil ™ 61 LAB CGRP 61 Therapeutic Competitors Report 61 induced mucositis 61 experimental antibiotic Trovan 61 DNA methylation biomarkers Epigenomics 61 Lisofylline 61 exclusive sublicense 61 relapsed leukemia 61 rheumatoid arthritis psoriasis 61 Ganciclovir 61 hypereosinophilic syndrome 61 commercialize telaprevir 61 chimeric antibody 61 PGL# 61 miRNA therapeutics 61 generation nucleoside analog 61 advanced metastatic renal 61 brand ciclesonide HFA 61 Ozarelix 61 sirtuin inhibitor program 61 Reata Pharmaceuticals 61 TOLMAR Holding Inc. 61 Nasdaq LXRX biopharmaceutical 61 PNT# 61 SinuNase ™ 61 Vaxfectin formulated 61 InterfeRx TM 61 NS5B polymerase 61 synthetic peptide containing 61 Ferring Pharmaceuticals privately 61 Allos retains exclusive 61 NXL# 61 Iluvien ® 61 Emtriva Viread 61 MolecularBreeding 61 lupus hepatitis C 61 Shigatoxin producing E. coli 61 Elan NanoCrystal 61 5 HT2A inverse 61 developed preclinically 61 candidate TNFerade biologic 61 SUTENT ® 61 SINOVAC BIOTECH LTD 61 homocysteine assay 61 ATL# [002] 61 HuMax EGFr 61 subcutaneous depot 61 Submits NDA 61 leading lipid nanoparticle 61 anti CD# antibodies 61 Intravitreal injections 61 anticoagulant reversing agent 61 topical gel formulation 61 dietary supplement formulated 61 Thiarabine 61 alvespimycin 61 HepDirect 61 sodium thiosulfate STS 61 include Alferon N 61 CIMZIA r 61 Vitaxin 61 Systemic Delivery 61 nucleoside polymerase inhibitor 61 Ceflatonin 61 BioSante Pharmaceuticals Announces 61 virotherapy 61 Angiotensin Converting Enzyme 61 Sphingomab 61 gefitinib Iressa 61 APC Targeting Technology 61 HIV integrase inhibitors 61 targeted anticancer therapeutics 61 Edurant 61 mGluR5 PAM 61 Astellas Deutschland GmbH 61 ProMune 61 GlaxoSmithKline Tykerb 61 pregabalin Lyrica 61 chemotherapy cisplatin 61 Intravenous CP 61 modified glutathione analog 61 Nasdaq CGEN 61 selective androgen receptor modulator 60 MorphoSys proprietary 60 Licenses Novel 60 novel peptides 60 tests miRview TM 60 CYT# NicQb 60 oncolytic 60 Regeneron Pharma 60 Vidaza R 60 GIPET 60 AFFITOME 60 HCV protease inhibitors 60 thiazolides 60 XmAb 60 Fortovase 60 initiated Phase Ib 60 Salmonella vector 60 pemetrexed Alimta 60 antimitotic 60 ESPRIT therapy 60 MediVas 60 cervical prostate 60 3TC lamivudine 60 NASDAQ CGEN announced 60 NB S# strontium malonate 60 pelvic malignancies 60 Cancidas 60 tin ib targets 60 Panzem R 60 vaccine GRNVAC1 60 Plasma Converter TM 60 ribavirin Copegus 60 AdVac 60 cromolyn sodium 60 Humira adalimumab 60 malignant mesothelioma Alfacell 60 UCB Keppra 60 LSE ASM 60 Nasdaq MNKD focused 60 hepatitis B immune globulin 60 cladribine Cladribine Tablets 60 Taiho Pharmaceutical 60 INSPIRE Trial Phase III 60 rheumatoid arthritis thrombocytopenia 60 colorectal lung 60 technology visit http:/www.genmab.com 60 Viral Immunotherapy platform 60 small molecule Hedgehog 60 TBC M4 60 Nasulin TM 60 proprietary VLP 60 oral picoplatin 60 Synerx Pharma 60 Devout Muslims refrain 60 Sym# 60 Aviptadil 60 Evoltra ® 60 RetroMetabolic Drug Design 60 CTLA4 Ig 60 HYLENEX recombinant 60 protein kinase inhibitor 60 pediatric malignancies 60 tests miRview ™ 60 aldehyde dehydrogenase ALDH2 deficiency 60 CCR5 mAb 60 oral salmon calcitonin 60 Therapeutic Competitors Companies 60 SECTA therapy 60 About Positron Positron 60 Farfan Juan Pablo 60 Cyclosert TM 60 drug pipeline TAFA# 60 Pazopanib 60 ARRY # 60 Novartis Trileptal 60 Solazed TM 60 Glufosfamide 60 Mipomersen 60 triggers apoptosis programmed 60 PEGylated Fab fragment 60 selective A2A adenosine receptor 60 name Cetrotide R 60 ErbB3 HER3 60 Cyclosert 60 Myriad logo BRACAnalysis 60 Pentad TM 60 thymidylate synthase TS 60 SHP LN 60 Phusion Laboratories 60 Fovea Pharmaceuticals subsidiary 60 coronary stent merged 60 dirucotide MBP# 60 Aptamer 60 PNP inhibitor 60 Tibotec Pharmaceuticals Ltd. 60 topical anti infective 60 brivanib 60 VentiRx